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Activation of IP3 receptors requires an endogenous 1-8-14
calmodulin-binding motif
Yi SUN1,2, Ana M. ROSSI1, Taufiq RAHMAN and Colin W. TAYLOR3
Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, U.K.
Binding of IP3 (inositol 1,4,5-trisphosphate) to the IP3-binding
core (residues 224–604) of IP3Rs (IP3 receptors) initiates opening
of these ubiquitous intracellular Ca2 + channels. The mechanisms
are unresolved, but require conformational changes to pass
through the suppressor domain (residues 1–223). A calmodulin-
binding peptide derived from myosin light chain kinase uncouples
these events. We identified a similar conserved 1-8-14 calmodulin-
binding motif within the suppressor domain of IP3R1 and, using
peptides and mutagenesis, we demonstrate that it is essential for
IP3R activation, whether assessed by IP3-evoked Ca2 + release
or patch-clamp recoding of nuclear IP3R. Mimetic peptides
specifically inhibit activation of IP3R by uncoupling the IP3-
binding core from the suppressor domain. Mutations of key
hydrophobic residues within the endogenous 1-8-14 motif mimic
the peptides. Our results show that an endogenous 1-8-14 motif
mediates conformational changes that are essential for IP3R
activation. The inhibitory effects of calmodulin and related
proteins may result from disruption of this essential interaction.
Key words: 1-8-14 motif, calcium signalling, calmodulin, inositol
1,4,5-trisphosphate receptor, myosin light chain kinase (MLCK).
INTRODUCTION
Ca2 + channels allow most electrical and many chemical signals
to be transduced into the changes in cytosolic Ca2 + concentration
that regulate almost every aspect of cellular activity [1]. Most
Ca2 + channels are also regulated by Ca2 + , either directly or via
CaM (calmodulin) [2]. This provides feedback regulation of Ca2 +
signalling and it allows Ca2 + channels to evoke regenerative
Ca2 + signals [3]. The latter are important because they underpin
the versatility of Ca2 + as an intracellular messenger, permitting it
to function either locally or globally [1].
Two major families of intracellular Ca2 + channels, IP3Rs [IP3
(inositol 1,4,5-trisphosphate) receptors] and RyRs (ryanodine
receptors), share many structural [4,5] and functional [5–7]
properties. Most notably, all IP3Rs and RyRs are stimulated by
low concentrations of cytosolic Ca2 + and inhibited by higher
concentrations. Ca2 + -binding sites within the RyR itself can
mediate this biphasic Ca2 + regulation [7], but, for IP3Rs, it
remains unclear whether additional Ca2 + -binding proteins are
required [6]. None of the many Ca2 + -binding sites in RyRs
[8] or IP3Rs [9] has been unambiguously associated with Ca2 +
regulation of channel gating [10,11], although mutation of a single
equivalent residue in RyRs or IP3Rs (Glu2100 in IP3R1) modulates
their Ca2 + -sensitivity [11]. Both families of intracellular Ca2 +
channels are also regulated by CaM, a ubiquitously expressed
and highly conserved Ca2 + -binding protein [12]. Related proteins
with EF-hand Ca2 + -binding structures, such as S100A and
CaBP1 (Ca2 + -binding protein 1), also regulate RyRs and IP3Rs,
but the physiological significance of these interactions between
intracellular Ca2 + channels and CaM or related proteins is
unresolved [13,14]. Despite some conflicting evidence [15], CaM
seems not to be essential for Ca2 + regulation of RyRs or IP3Rs
[16–18], but it does regulate both channels and it modulates their
responses to Ca2 + [19–21].
All IP3Rs are inhibited by Ca2 + –CaM [22], but neither of the
two CaM-binding sites within IP3R1, nor a third that is created by
alternative splicing [23], clearly mediates this inhibition of IP3-
evoked Ca2 + release. The central site [24] (Figure 1A) mediates
neither Ca2 + nor CaM regulation of IP3R activity [16,17] and it is
absent from IP3R3. The functional role of the split N-terminal site
(Figure 1A), one component of which may also bind CaBP1 [25],
is also unclear. It has been proposed to bind CaM and thereby to
inhibit IP3R activity, but only when Ca2 + has bound elsewhere
[26]. The evidence that CaM inhibits IP3R only in the presence of
Ca2 + , without CaM itself providing the Ca2 + -sensor, is persuasive
[26], but there is no compelling evidence to link this to the
N-terminal CaM-binding site [27].
The links between CaM binding and function are better
understood for RyRs, although the effects differ between RyR
subtypes [7]. A single site on each RyR1 subunit (residues 3614–
3643 in rabbit RyR1), which is conserved in all RyRs, binds the
C-terminal lobe of both apo-CaM and Ca2 + –CaM and appears to
mediate the functional effects of CaM [20,28,29]. As this tethered
CaM binds Ca2 + , it migrates towards the NT (N-terminus) of
the binding site and the CaM switches from activating RyR1 to
inhibiting it [19]. The CaM-binding site of RyR1 also engages
other CaM-like domains, notably the C-terminus of the L-type
Ca2 + channel which inhibits RyR1 activity [30], and perhaps
an EF-hand-like structure within the C-terminal region of RyR1
which binds Ca2 + and modulates Ca2 + regulation of RyR [31].
These observations suggest that the CaM-binding domain of RyR
also mediates important inter- and intra-molecular interactions,
and that the complex effects of CaM and related proteins may, at
least in part, result from disrupting these interactions [29,31,32].
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Figure 1 A putative 1-8-14 motif within the SD of the IP3R
(A) Key features of a rat IP3R showing the NT, with its component parts (SD and IBC), the six C-terminal transmembrane domains (TMD) that form the pore and the CaM-binding domains (yellow).
Residue numbers are shown. (B) Comparison of 1-8-14 motifs showing the conserved hydrophobic residues of the consensus sequence in blue. Charged residues within the 1-8-14 motif are
highlighted in red because the consensus motif has a net charge of + 3 to + 6. The lower panel shows the peptides used with mutated residues underlined. (C) Structure of the SD of IP3R1 (PDB
code 1XZZ) and the equivalent region (A domain) of RyR1 (PDB code 3HSM) with the pseudo-1-8-14 motif highlighted and compared with MLCK in the structure it adopts when bound to Ca2 + –CaM
(PDB code 1QTX).
For IP3Rs, IP3 binding to the IBC (IP3-binding core) (residues
224–604) (Figure 1A) initiates the conformational changes
that lead to opening of a pore formed by the C-terminal
transmembrane domains of each of the four IP3R subunits
[5,33]. These conformational changes pass via the N-terminal
SD (suppressor domain) (residues 1–223), which is essential
for IP3R activation. Indeed, the major conformational changes
associated with IP3R activation appear to occur within the NT
(residues 1–604) [5,33]. Although both IP3 and Ca2 + are
required for IP3R activation [6,34], it is not yet clear how the
conformational changes initiated by IP3 lead to Ca2 + binding and
then to gating of the pore. It is therefore intriguing that a CaM-
binding peptide derived from MLCK (myosin light chain kinase),
which comprises a 1-8-14 CaM-binding sequence [35], reversibly
inhibits IP3-evoked Ca2 + release [36] via all three vertebrate
IP3R subtypes. Furthermore, MLCK peptide is more potent in
the presence of Ca2 + [35]. This inhibition is entirely independent
of CaM and involves interaction of MLCK peptide with the NT
in a manner that requires the SD [35]. We speculate, by analogy
with RyRs, that inhibition of IP3Rs by MLCK peptide might result
from disruption of an interaction between endogenous CaM-like
and CaM-binding domains within IP3Rs, and that, for IP3Rs, this
interaction is essential for activation. In the present study, we
explored this hypothesis further.
EXPERIMENTAL
Materials
Cell culture materials were from Gibco, except for fetal bovine
serum (Sigma). CaM purified from bovine brain was from
Calbiochem. [3H]IP3 (18 Ci/mmol) was from PerkinElmer. IP3
was from Alexis Biochemicals. Peptides were synthesized and
purified by Sigma or New England Peptide, and each was
shown to be >90% pure by HPLC. The peptide sequences are
listed in Supplementary Table S1 (at http://www.biochemj.org/bj/
449/bj4490039add.htm).
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Site-directed mutagenesis
The NT (residues 1–604) and IBC (residues 224–604) of rat
IP3R1 were amplified by PCR from the full-length receptor
clone lacking the SI splice region (GenBank® accession number
GQ233032.1) as described previously [33]. The fragments were
ligated into pTrcHis A (Invitrogen) to allow expression of
N-terminally His6-tagged proteins. Mutagenesis of the 1-8-14
motif within the NT used the QuikChange® II XL site-directed
mutagenesis kit (Stratagene) for single mutants (F53E, L60E,
Y66E and K52E) and the QuikChange® multi-site-directed
mutagenesis kit for the double mutant (F53E and Y66E).
The primers used are listed in Supplementary Table S2 (at
http://www.biochemj.org/bj/449/bj4490039add.htm). The same
primers and conditions were used for mutagenesis of full-length
IP3R using IP3R1 in the pENTR 1A vector. Full-length constructs
were subcloned into pcDNA3.2/V5-DEST for expression in DT40
cells. The complete sequence of every mutant construct was
verified by sequencing.
Culture and stable transfection of DT40 cells
DT40 cells in which the genes for all three IP3R subtypes had
been disrupted (DT40-KO) [37] and DT40 cells stably expressing
rat IP3R1 (DT40-IP3R1) were grown in RPMI 1640 medium
supplemented with 10% (v/v) fetal bovine serum, 1% (v/v)
heat-inactivated chicken serum, 2 mM L-glutamine and 50 μM
2-mercaptoethanol. Cells were grown in suspension in 175 cm2
flasks at 37 ◦C in an atmosphere of 5% CO2. They were used
or passaged when they reached a density of ∼2×106 cells/ml.
To generate stable cell lines expressing mutant IP3R, the mutant
construct in pcDNA3.2/V5-DEST was linearized, and DT40 cells
were transfected by nucleofection (Amaxa, protocol B-23). Cell
lines were selected with G-418 (2 mg/ml) and screened initially
by Western blotting using a peptide antiserum to IP3R1 [38]
as described previously [33], and then using the functional assay
described below.
Ca2 + release from the intracellular stores of permeabilized cells
The free Ca2 + concentration of the intracellular stores of
permeabilized cells was measured using a low-affinity Ca2 +
indicator trapped within the endoplasmic reticulum as reported
previously [39]. Briefly, DT40 cells (4×107 cells/ml) were
suspended in HBS (Hepes-buffered saline: 135 mM NaCl,
5.9 mM KCl, 11.6 mM Hepes, 1.5 mM CaCl2, 11.5 mM glucose
and 1.2 mM MgCl2, pH 7.3) containing 1 mg/ml BSA, 0.4 mg/ml
Pluronic F127 and 20 μM mag-fluo-4/AM (Invitrogen). After 1 h
at 20 ◦C in the dark with gentle shaking, cells were centrifuged at
650 g for 2 min and resuspended to 107 cells/ml in Ca2 + -free CLM
(cytosol-like medium) (20 mM NaCl, 140 mM KCl, 1 mM EGTA,
20 mM Pipes and 2 mM MgCl2, pH 7.0) containing 20 μg/ml
saponin. After incubation at 37 ◦C with gentle shaking for 4 min,
permeabilized cells were centrifuged at 650 g for 2 min and
resuspended in Mg2 + -free CLM, supplemented with CaCl2 to
give a final free Ca2 + concentration of 220 nM. The free Ca2 +
concentration of CLM was calculated using the MaxChelator
program (http://maxchelator.stanford.edu) and then measured
using fluo-3 or fura-2. Cells were then washed, resuspended
in Mg2 + -free CLM containing 10 μM FCCP (carbonyl cyanide
p-trifluoromethoxyphenylhydrazone) to inhibit mitochondria, and
distributed into a 96-well plate (106 cells in 50 μl of CLM/well).
After centrifugation, fluorescence from the luminal indicator was
recorded using a FlexStation II platereader (Molecular Devices)
equipped to allow automated additions [39]. In all experiments,
the intracellular stores were allowed to load to steady-state
with Ca2 + after addition of MgATP. IP3 was then added with
thapsigargin (1 μM, to inhibit Ca2 + reuptake). The Ca2 + release
evoked by IP3 is expressed as a fraction of the ATP-dependent
Ca2 + uptake.
Patch-clamp recording
Currents were recorded from patches excised from the outer
nuclear envelope of DT40 cells expressing recombinant rat
IP3R1 using symmetrical caesium methanesulfonate (140 mM)
as the charge-carrier. The composition of recording solutions
and methods of analysis were otherwise as described previously
[40].
Expression of N-terminal fragments of IP3R
The pTrcHis constructs were used for expression of N-terminally
His6-tagged proteins in Escherichia coli strain BL21(DE3) cells.
Before use for [3H]IP3 binding, proteins were cleaved from the
His6 tags using biotinylated thrombin (Novagen) at the engineered
thrombin-cleavage site [33]. Complete cleavage was verified by
Western blotting using an anti-His6 antibody. The proteins were
used for [3H]IP3 binding without further purification [33].
[3H]IP3 binding
Equilibrium-competition binding assays were performed at 4 ◦C
for 5 min in CLM (500 μl) with a free Ca2 + concentration of
220 nM and containing [3H]IP3 (0.75–1.5 nM), bacterial lysate
(10 μg of protein for IBC and 100 μg of protein for NT) or
cerebellar membranes (50 μg of protein) and competing ligands.
Non-specific binding was defined by addition of 10 μM IP3.
Bound and free [3H]IP3 were separated by centrifugation at
20000 g for 5 min, after addition of poly(ethylene glycol) (15%
final concentration) and γ -globulin (0.75 mg) for soluble proteins.
Results were analysed by fitting to a Hill equation (using
GraphPad Prism) from which the IC50 (half-maximal inhibitory
concentration) and thereby the Kd (equilibrium dissociation
constant) were calculated [33].
Western blotting
Cells in Ca2 + -free CLM containing 2-mercaptoethanol (1 mM)
and protease inhibitors were lysed by addition of PopCulture
(10%), lysozyme (10 μg/ml), DNAse (5 units/ml) and RNAse
(10 μg/ml). The proteins were separated using SDS/PAGE
pre-cast mini-gels (Invitrogen) and transferred on to a
PVDF membrane using an Iblot dry-transfer apparatus
(Invitrogen). The primary antibodies were rabbit anti-His6
(1:3000 dilution) (Sigma) and anti-IP3R1 (1:1000 dilution) [33].
HRP (horseradish peroxidase)-conjugated anti-rabbit secondary
antibodies (1:5000 dilution) (AbCam) and the Super Signal
West Pico chemiluminescence reagent (Pierce) were used to
detect immunoreactivity. Bands were quantified using GeneTools
software (Syngene).
Statistical analysis
For comparisons of Kd, EC50 (half-maximally effective
concentration) or IC50 values, their negative logarithms (pKd,
pEC50 and pIC50; means +− S.E.M.) were used for statistical
analyses. For clarity, some Figures show normalized results, but
all statistical analyses were performed on the raw data using
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paired or unpaired Student’s t tests. P < 0.05 was considered
significant.
RESULTS AND DISCUSSION
Reversible inhibition of IP3-evoked Ca2 + release by an
endogenous 1-8-14 peptide
A sequence within the SD of all known IP3Rs (residues 53–66 in
rat IP3R1; Supplementary Figure S1 at http://www.biochemj.
org/bj/449/bj4490039add.htm) includes the critical hydrophobic
residues of a 1-8-14 CaM-binding motif appropriately oriented
within the known structure of the SD [41] (Figures 1B and 1C)
and with the required net positive charge [35]. The sequence
lies within one of the two regions (residues 49–81; Figure 1A)
within the NT reported to bind CaM [42] and CaBP1 [14]. A
similar sequence is present within the N-terminal of all RyRs
(Supplementary Figure S1). To test our hypothesis that inhibition
of IP3R by MLCK peptide results from disruption of an essential
interaction involving an endogenous 1-8-14 motif, we assessed
the effects of a peptide derived from this motif (1-8-14 peptide;
Figure 1B and Supplementary Table S1) on IP3-evoked Ca2 +
release.
The 1-8-14 peptide inhibited IP3-evoked Ca2 + release via IP3R1
without affecting either Ca2 + uptake or the sensitivity (EC50) to
IP3 (Figures 2A–2D). A maximally effective concentration of
the peptide reduced the maximal response to IP3 by 77 +− 7%.
The IC50 for 1-8-14 peptide was 767 μM (pIC50, 3.1 +− 0.25)
(Figure 2C). Neither a mutant 1-8-14 peptide, in which two
critical hydrophobic residues are mutated (1-8-14C, 3 mM) nor
a scrambled peptide (1-8-14S, 3 mM) had any effect on IP3-
evoked Ca2 + release (Figure 2C). Both MLCK peptide (isoelectric
point, pI 14.0) and 1-8-14 peptide (pI 11.6) are very basic
and might therefore have inhibited IP3-evoked Ca2 + release by
binding directly to IP3. We demonstrated previously that this was
not the case for MLCK peptide [35], and it is also unlikely
for the 1-8-14 peptide. The 1-8-14 and 1-8-14S peptides are
equally basic, but only the former inhibited IP3R; the percentage
inhibition caused by 3 mM 1-8-14 peptide is similar for all IP3
concentrations (∼75%), and neither was the inhibition reduced
by increasing the IP3 concentration beyond that required to
stimulate maximal Ca2 + release (Figure 2B). We conclude that
1-8-14 peptide inhibits IP3-evoked Ca2 + release by binding to
IP3R.
The 1-8-14 peptide is only 16 residues long. A longer peptide
(30 residues, 1-8-14L), which includes additional N- and C-
terminal residues that are conserved in all IP3Rs (Figure 1B and
Supplementary Figure S1), also inhibited IP3-evoked Ca2 + release
without affecting Ca2 + uptake (Figure 2D). Although IP3R may be
slightly more sensitive to the longer peptide (IC50, 326 μM; pIC50,
3.5 +− 0.25) than to the 1-8-14 peptide (767 μM, 3.1 +− 0.25);
the difference was not statistically significant. Subsequent
studies used the shorter 1-8-14 peptide because it was less
expensive.
The results shown in Figure 2(E) demonstrate that the effects
of a maximally effective concentration of 1-8-14 peptide (3 mM)
are fully reversible. These experiments, which require extensive
washing of the cells between successive challenges with the
peptide, confirm that the inhibition of IP3Rs by the 1-8-14 peptide,
like that by MLCK peptide [35], does not result from dissociation
of CaM from IP3R [36]. Our previous study demonstrated that
MLCK peptide more potently inhibited IP3R when the cytosolic
free Ca2 + concentration was increased [35]. Similar results were
obtained with 1-8-14 peptide (Figure 2F). We conclude that
1-8-14 peptide inhibits IP3-evoked Ca2 + release by binding to
the IP3R and the inhibition is enhanced at elevated cytosolic Ca2 +
concentrations.
Inhibition of single-channel currents through IP3Rs by 1-8-14
peptide
In patch-clamp recordings from the nuclear envelope of DT40
cells expressing rat IP3R1, a maximally effective concentration
of IP3 stimulated IP3R activity and this was massively attenuated
by the 1-8-14 peptide (3 mM) (Figures 3A and 3B). Our results
are consistent with the peptide causing a 50% decrease in the
mean channel open time (τ o) (Figure 3C). However, the overall
channel activity (NPo) was so low under these conditions that we
cannot reliably estimate the number of active IP3Rs (N) within
each patch. We cannot therefore entirely eliminate the possibility
that each patch fortuitously included several IP3Rs and that their
clustering caused τ o to fall from ∼10 ms to ∼5 ms as we reported
previously [40]. An effect on τ o would be unusual because most
regulators of IP3Rs affect the duration of closed states (τ c) [6,40].
The effect of the peptide on τ o is not, however, sufficient to
account for the ∼10-fold decrease in NPo (Figure 3A), suggesting
that the 1-8-14 peptide must also affect the rate of channel opening
(i.e. τ c). Because it was impossible to determine the number of
active IP3Rs in the presence of 1-8-14 peptide (see above), we
could not reliably determine τ c. The single-channel conductance
(γ Cs) was unaffected by 1-8-14 peptide: it was 214 +− 6 pS (n = 3)
and 209 +− 6 pS (n = 3) for control and peptide-treated IP3Rs
respectively (Figure 3D).
These results establish that a peptide derived from an
endogenous 1-8-14 motif within the SD of the IP3R is similar
to MLCK peptide in causing substantial and reversible inhibition
of IP3Rs that is independent of CaM. This conclusion is
consistent with our suggestion that MLCK peptide inhibits IP3Rs
by mimicking an endogenous 1-8-14 motif, and so perhaps
‘unzipping’ an interdomain interaction [43] that is essential for
activation of IP3Rs.
1-8-14 peptide uncouples IP3 binding from activation of IP3Rs
Removal of the SD increases the affinity of both full-length IP3Rs
and the NT for IP3 [33]. We [33] have suggested that this reflects
the use of binding energy to drive conformational rearrangement
of SD-IBC interfaces during the initial steps of IP3R activation
[5,44].
1-8-14 peptide (3 mM) increased specific binding of [3H]IP3 to
full-length IP3R1. Similar results were obtained with the NT,
but IP3 binding to the IBC was unaffected (Figure 4A). The
latter demonstrates that 1-8-14 peptide does not interact directly
with either the IP3-binding site or with IP3. Neither the mutated
(1-8-14C) nor scrambled (1-8-14S) peptide had any effect on
IP3 binding to the NT (Figure 4A). These results with IP3R
fragments expressed in E. coli, which lack CaM, also further
support our conclusion that the effects of 1-8-14 peptide are
entirely independent of CaM.
Comparison of the effects of 1-8-14 peptide on stimulating
[3H]IP3 binding to the NT (EC50, 615 μM; pEC50, 3.21 +− 0.19)
(Figure 4B) with its inhibitory effect on IP3-evoked Ca2 + release
(IC50, 767 μM; pIC50, 3.1 +− 0.25) (Figure 2C) demonstrates that
each is similarly sensitive to the peptide. These results are
consistent with our hypothesis that the 1-8-14 peptide disrupts
an interaction between the SD and IBC that is essential for IP3R
activation. The peptide thereby inhibits IP3-evoked Ca2 + release
(Figure 2) and IP3R activity (Figure 3) and, by uncoupling IP3
binding from subsequent conformational changes, it stimulates
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Figure 2 Inhibition of IP3R by 1-8-14 peptide
(A) Typical recording of the free Ca2 + concentration within the endoplasmic reticulum of a population of permeabilized DT40-IP3R1 cells showing Ca2 + uptake after addition of MgATP (1.5 mM),
release of Ca2 + after addition of IP3 (10 μM, with 1 μM thapsigargin to inhibit Ca2 + re-uptake) and inhibition of that release by 1-8-14 peptide (3 mM, present throughout as indicated, upper
trace). Results are means +− S.E.M. for three replicates from a single experiment. (B) Concentration-dependent release of intracellular Ca2 + stores by IP3 alone or after pre-incubation for 2.5 min
with 1-8-14 peptide (3 mM). Inhibition by 1-8-14 peptide at each IP3 concentration is also shown (%). 1-8-14 peptide caused a significant decrease in the maximal response (P < 0.001) without
significantly changing the sensitivity to IP3. (C and D) Permeabilized cells pre-incubated for 10–20 min with the indicated concentrations of peptide were stimulated with IP3 (10 μM, in the continued
presence of peptide). Results show the Ca2 + content of the stores before addition of IP3, and the Ca2 + release evoked by IP3. (E) Permeabilized cells were incubated alone or with 1-8-14 peptide
(3 mM) for 10–20 min, washed and then resuspended in CLM. Ca2 + release by IP3 (10 μM) was then measured after a further incubation for 10–20 min with the indicated concentrations of 1-8-14
peptide. The Ca2 + release evoked by IP3 with and without peptide is shown for naive cells and after the pre-treatment with 3 mM peptide. The results establish that the effects of 1-8-14 peptide are
fully reversible. (F) Permeabilized cells pre-incubated with or without 1-8-14 peptide (1 mM) for 10–20 min were stimulated with a maximally effective concentration of IP3 in the continued presence
of peptide in CLM with the indicated free Ca2 + concentration. Results show the inhibition of IP3-evoked Ca2 + release (%) by 1-8-14 peptide at each free Ca2 + concentration. Results in (B)–(F)
are means +− S.E.M. (n 3). *P<0.05, **P<0.01 and ***P<0.001.
IP3 binding (Figure 4). Subsequent experiments used mutagenesis
of residues within the endogenous 1-8-14 motif to test this
hypothesis further.
Mutations within the endogenous 1-8-14 sequence increase
IP3-binding affinity
If, as we suggest, the 1-8-14 peptide disrupts an essential
interaction between the endogenous 1-8-14 sequence and another
domain within the NT, we might expect mutation of appropriate
residues in the SD to both disrupt IP3R activation and
increase IP3-binding affinity. We tested the latter prediction by
examining IP3 binding to the NT in which each of the critical (1,
8 and 14) hydrophobic/aromatic residues that are important for
Ca2 + –CaM binding to 1-8-14 motifs [45] was replaced with a
charged hydrophilic residue (glutamate). The same hydrophobic
residues are essential for MLCK [35] and 1-8-14 (Figure 2C)
peptides to disrupt IP3R activation.
NTs of IP3R1 with point mutations in positions equivalent
to the 1- (F53E), 8- (L60E) or 14-position (Y66E) of the
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Figure 3 Inhibition of IP3R gating by 1-8-14 peptide
(A) Typical recordings from excised nuclear patches stimulated with IP3 (10 μM) with and without 1-8-14 peptide (3 mM) in the pipette solution. The holding potential was + 40 mV. The closed state
is shown. (B and C) NPo (B) and τ o (C) for IP3R stimulated with IP3 alone or with 1-8-14 peptide (3 mM, + Pep). Results for IP3RL60E are also shown. *P<0.05, ***P<0.001 and ****P<0.0001
relative to native IP3R without peptide. (D) Single-channel current (i)–voltage (V) relationships for the three stimulation conditions. Results in (B)–(D) are means +− S.E.M. (n 3).
Figure 4 1-8-14 peptide directly stimulates IP3 binding to the NT of IP3R
(A) Specific equilibrium binding of [3H]IP3 (1.5 nM) to membranes from rat cerebellum
(full-length IP3R, FL) or to isolated NT or IBC, alone or in the presence of 3 mM of the
indicated peptide. *P<0.05 and **P<0.01 relative to control; comparisons were performed on
the raw data. (B) Concentration-dependent effects of 1-8-14 peptide on specific [3H]IP3 binding
to NT in CLM with 220 nM free Ca2 + concentration, plotted as the increase in specific [3H]IP3
binding as a percentage of that evoked by the maximal concentration of peptide. Results are
means +− S.E.M. (n 3).
endogenous 1-8-14 motif (Figure 1A) were expressed in E.
coli. Expression levels of the NT and its mutants were not
identical (Figure 5A), but they were each sufficient to allow the
affinity for IP3 and the effects of peptides to be determined after
cleavage of the His6 tag, but without further purification [33].
As expected, IP3 bound to the IBC with greater affinity (17-
fold) than to the NT (Figure 5B) [33,46,47], consistent with
our suggestion that, in the absence of the SD, less binding
energy is diverted into conformational changes [33]. Mutation of
critical residues within the endogenous 1-8-14 motif significantly
increased the affinity of the NT for IP3 (Figure 5B and Table 1),
although none was as effective as complete removal of the SD.
This is consistent with our observation that neither the 1-8-14
(Figure 2) nor MLCK [35] peptide entirely inhibits IP3-evoked
Ca2 + release, whereas removal of the SD totally uncouples
IP3 binding from IP3R activation [48]. Although maximally
effective concentrations of MLCK (100 μM) or 1-8-14 (3 mM)
peptides similarly increased IP3 binding to the NT, neither peptide
had any effect on [3H]IP3 binding to the NT with mutations
in any of the critical 1-8-14 residues (Figures 5C and 5D).
Mutation of a residue immediately preceding the critical 1-
position of the 1-8-14 motif (K52E), which did not increase
the affinity of IP3 for the NT (Supplementary Figure S2A
at http://www.biochemj.org/bj/449/bj4490039add.htm), had no
effect on the responses to MLCK or 1-8-14 peptides (Figures 5C
and 5D) and neither did it affect IP3-evoked Ca2 + release
[33] (Supplementary Figure S2B). These results establish that
mutation of critical residues within the endogenous 1-8-14 motif
selectively increases IP3-binding affinity and these effects are
non-additive with those of either MLCK or 1-8-14 peptide.
Mutations within the 1-8-14 motif selectively increase agonist
affinity
Our hypothesis is that the apparent affinity of agonists (such as
IP3) for native IP3Rs is reduced because some of their binding
energy is diverted into the conformational changes that activate
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Figure 5 Mutations within the 1-8-14 motif mimic the effect of 1-8-14 peptide on IP3 binding
(A) Western blot (typical of three independent experiments) with an anti-His6 antibody of lysates (5 μg of protein/lane) from bacteria expressing NT with the indicated mutations. The 80 kDa
molecular-mass marker is shown. (B) Concentration-dependent effect of IP3 on specific [3H]IP3 binding to the IBC, NT and mutated NT. (C and D) Effects of MLCK peptide (C, 100 μM) and 1-8-14
peptide (D, 3 mM) on specific binding of [3H]IP3 (1.5 nM) to the NT and the indicated mutants (each expressed as a percentage of the control). (E) Specific binding of [3H]IP3 (1.5 nM) to the
IBC, NT and mutated NT in the presence of the indicated concentrations of heparin. (F) Summary results from experiments similar to those in (E) showing the K d for IP3 and heparin binding to the IBC,
NT and mutated NT. Results in (B)–(F) are means +− S.E.M. (n 3). *P<0.05, **P<0.01 and ***P<0.001 relative to control; comparisons were performed on the raw data.
Table 1 Binding of IP3 and heparin to N-terminal fragments of IP3R1
Equilibrium competition binding using [3H]IP3 was used to measure the pK d of IP3 and heparin
for the N-terminal fragments of IP3R1. Affinities for ligands are also shown expressed as fold
increase relative to wild-type NT (i.e. K dNT/K dmutant). Results are means +− S.E.M. (n 3).
*P < 0.05, **P < 0.01 and ***P < 0.001 relative to NT.
pK d, /M IP3 Affinity pK d, /g/ml heparin Affinity
Fragment (K d, nM) relative to NT (K d, ng/ml) relative to NT
NT 7.40 +− 0.11 (40.0) 1 6.62 +− 0.06 (239) 1
F53E 7.97 +− 0.05** (10.8) 4 6.92 +− 0.06** (120) 2
L60E 7.84 +− 0.08* (14.5) 3 6.70 +− 0.04 (200) 1.2
Y66E 7.64 +− 0.04 (22.8) 2 6.77 +− 0.03 (171) 1.4
IBC 8.62 +− 0.05*** (2.4) 17 6.93 +− 0.04** (117) 2.0
the IP3R [33]. Antagonists, because they need not evoke the
rearrangement of the IBC and SD that initiates IP3R activation,
may be less affected by disruption of these interactions. We
therefore examined the effects of the SD and of point mutations
within the endogenous 1-8-14 sequence on binding to the NT
of heparin, a competitive antagonist of IP3 [49]. The results
demonstrate that, whereas removal of the SD increased the affinity
of the NT for IP3 17-fold, it caused only a 2-fold increase in the
affinity for heparin. Point mutations within the endogenous 1-8-
14 motif also caused larger increases in the affinity for IP3 than
for heparin (Figures 5E and 5F, and Table 1). These results are
important because they demonstrate that the effects of the SD and
of mutations within the 1-8-14 sequence on ligand binding are
specific for an agonist of the IP3R. They thereby demonstrate the
importance of the 1-8-14 motif in specifically mediating activation
of IP3Rs.
Mutations within the endogenous 1-8-14 motif uncouple IP3
binding from gating of IP3Rs
It proved difficult to establish stable DT40 cell lines expressing
rat IP3R1 in which critical residues within the 1-8-14 motif were
mutated, but we succeeded with two mutants (Figure 6A). The
first (IP3RL60E) is mutated at the 8-position of the 1-8-14 motif
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Figure 6 The endogenous 1-8-14 motif is essential for activation of IP3R
(A) Expression of IP3R1 in DT40 cells stably expressing each of the indicated mutants. Each lane was loaded with 4×103 cells and probed with antisera to IP3R1 (upper panel) or β-adaptin (lower
panel). The R568Q mutant (which reduces the affinity of the IP3R for IP3) [50] is shown because it provides a control for functional assays of cells expressing IP3R at low density. Molecular-mass
markers are shown on the right. The Western blot is typical of three independent experiments. The lower panel shows summary results (means +− S.E.M., n = 3), where IP3R expression was calculated
from blots that included DT40-IP3R1 membranes in which levels of expression were established by equilibrium competition [3H]IP3 binding. (B) Typical responses to IP3 (10 μM) from DT40 cells
lacking IP3R (KO) or expressing wild-type IP3R1 or IP3R with the indicated mutations (see the text for details). (C) Summary results show the Ca2 + content of the loaded stores () and the Ca2 +
released by IP3 (histograms) for each of the indicated cell lines. (D) Specific [3H]IP3 binding (1.5 nM) to full-length IP3R (FL) with the indicated mutations (L60E or FY, see the text for details) in
permeabilized DT40 cells alone or in the presence of 100 μM MLCK peptide. Results in (C) and (D) are means +− S.E.M. (n 3). (E) Typical records from active excised nuclear patches of DT40
cells expressing IP3R1 or IP3R1L60E stimulated with IP3 (10 μM). The holding potential was + 40 mV. C denotes the closed state. Summary data are provided in Figures 3(B)–3(D). **P<0.01,
***P<0.001 and ****P<0.0001 relative to IP3R1 (A and C) or control (D).
and the second has mutations at both the 1- (F53E) and 14-
positions (Y66E) (IP3RFY). As expected, a maximally effective
concentration of IP3 (10 μM) failed to stimulate Ca2 + release from
permeabilized DT40 cells lacking IP3R (DT40-KO cells) [37,40],
but it caused release of 81 +− 1% of the Ca2 + stores of DT40-
IP3R1 cells (Figures 6B and 6C). In the cell lines expressing IP3R
with a mutated 1-8-14 motif, there was barely detectable Ca2 +
release that was not significantly different from that observed
in DT40-KO cells (Figures 6B and 6C). ATP-dependent Ca2 +
uptake into the ER was similar for each cell line (Figure 6C).
We were concerned that the lower level of expression of mutant
IP3R relative to wild-type (∼30–50%, Figure 6A) might have
contributed to the lack of detectable IP3-evoked Ca2 + release.
However, in another stable DT40 cell line where the IP3-binding
site was mutated (R568Q), causing a ∼10-fold decrease in IP3
affinity [50], IP3R expression (∼15% of wild-type) was less than
half that of the cell lines with mutations in the 1-8-14 motif
(Figure 6A). Nevertheless, IP3 caused a readily detectable release
of Ca2 + from the intracellular stores of DT40-IP3RR568Q cells
(49 +− 2% of that detected in DT40-IP3R1 cells) (Figures 6B and
6C). We conclude that the lack of detectable Ca2 + release in cells
expressing IP3R with a mutant 1-8-14 motif is not attributable
to reduced IP3R expression. Neither is it likely that the lack of
response to IP3 from mutant IP3R reflects a more global disruption
of IP3R structure because each of the full-length mutant IP3Rs
bound IP3, although, as predicted, addition of MLCK peptide
increased IP3 binding to only the wild-type IP3R (Figure 6D).
Furthermore, DT40 cells expressing IP3R1 with a mutation in
an adjacent residue (DT40-IP3R1K52E) responded normally to IP3
[33] (Supplementary Figure S2B). These results are consistent
with the suggestion that mutations within the endogenous 1-8-14
motif mimic addition of exogenous MLCK peptide by uncoupling
IP3 binding from the conformational changes that lead to opening
of the IP3R pore. Single-channel analyses provide further support
for this conclusion.
Yamazaki et al. [51] reported recently the functional effects
of mutations within IP3R including some within the 1-8-14
motif (F53D and Y66A). We note, however, that some of their
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mutations, e.g. Y167A, which is clearly implicated in IP3R
activation, abolished IP3-evoked Ca2 + release from microsomes
without affecting Ca2 + signals evoked by activation of the BCR
(B-cell receptor) in intact cells. This unexplained disparity casts
some doubt over whether in these assays responses from intact
cells faithfully report the activity of IP3R. In DT40 cells expressing
an IP3R with five mutations that included Y66A (the 14-position
of the 1-8-14 motif), activation of the BCR evoked a Ca2 + signal,
suggesting that the mutant IP3R was functional [51]. However, in
this IP3R, the mutant had one hydrophobic residue replaced by
another and this might not radically affect the behaviour of the
1-8-14 motif. In preliminary analyses of cells expressing IP3Rs in
which the first position of the 1-8-14 motif was mutated (F53D),
Ca2 + signals were also observed after activation of the BCR [51].
This may reflect a limitation of the BCR-based assay (see above)
or it may provide evidence for a lesser role of the 1-position in
the 1-8-14 motif. We have not succeeded in establishing a DT40
cell line expressing IP3Rs with only this mutation, although our
results do clearly show that IP3Rs with mutations in both the 1-
and 14-positions (IP3RFY) are barely responsive to IP3 (Figure 6).
Mutation of the endogenous 1-8-14 motif attenuates IP3R gating
without affecting single-channel conductance
In keeping with the reduced expression of IP3RL60E in DT40 cells
(Figure 6A), the frequency with which functional IP3Rs were
detected in excised nuclear patches was much lower for nuclei
from paired experiments with DT40-IP3R1L60E cells (three of 48
patches) than from DT40-IP3R1 cells (five of 13 patches). In
parallel analyses, functional IP3Rs were never detected in DT40-
KO cells (none of 30 patches). The single-channel conductances
(γ Cs) of the mutant IP3RL60E (209 +− 8 pS) and normal IP3R
(214 +− 6 pS) were indistinguishable (Figure 3D), but NPo was
massively decreased in the mutant (Figures 3B and 6E). Our
interpretation of the latter is, as we described in our analyses
of the 1-8-14 peptide, limited by our inability, when NPo is
so low for IP3R1L60E, to estimate reliably the number of active
IP3R within a patch. Nevertheless, it is clear that the major effect
on single-channel behaviour of mutating the endogenous 1-8-14
motif of IP3R1 (Figures 3B–3D and 6E) and of adding
1-8-14 peptide to normal IP3R1 (Figure 3) is similar: both
decrease NPo without affecting γ Cs. These results establish that
mutations in the endogenous 1-8-14 motif or addition of 1-8-
14 peptide uncouple ligand binding from channel gating without
compromising the behaviour of the pore.
Conclusions: interactions between endogenous 1-8-14 and
CaM-like motifs mediate activation of IP3Rs
CaM [22] or related EF-hand-containing proteins [14,25],
peptides that comprise 1-8-14 CaM-binding motifs [35,36]
(Figures 2–4) or disruption of a conserved endogenous 1-8-14-
like motif within the SD of IP3Rs inhibit IP3-evoked Ca2 + release
(Figures 5 and 6) by massively reducing NPo of IP3R (Figures 3
and 6E). We conclude that an endogenous 1-8-14 motif within
the SD (Figure 1) is essential for IP3R activation. Where it has
been examined, the inhibitory proteins or peptides are more potent
when Ca2 + is bound to the IP3R [26,35] (Figure 2F). We therefore
speculate that the endogenous 1-8-14 motif may interact with an
unidentified domain that includes an EF-hand-like structure and
that these interactions might be related to Ca2 + regulation of
IP3R (Figure 7). We suggest that competing peptides (CaM-like
or 1-8-14 motifs) or mutagenesis of the endogenous 1-8-14 motif
inhibit IP3Rs by disrupting this essential interaction in a manner
Figure 7 Activation of IP3Rs requires an endogenous 1-8-14 motif
IP3 binding to the IBC initiates conformational changes that pass via the SD and lead, via
regulation of Ca2 + binding to the IP3R, to opening of the pore [33]. (A) An endogenous 1-8-14
motif within the SD is essential for IP3R activation. We speculate (upper panel) that interaction of
this CaM-binding motif (red, conserved hydrophobic residues in dark blue) with an endogenous,
but presently unknown, CaM-like structure (pale blue) within the NT may link IP3 binding to
Ca2 + binding. (B) Another possibility is that IP3 binding rearranges the 1-8-14 motif and so
repositions a critical acidic residue (Glu246) that may then contribute to a Ca2 + -binding site
(Ca-1) [55]. The NT without IP3 bound (PDB code 3UJ0) [5] is shown with the IBC in grey and
the SD in green to highlight Phe53 (within the 1-8-14 motif) and Phe223 to which it is closely
apposed (yellow box), residues proposed to form the Ca-1 site (pink box) and the β-sheet that
links Phe223 to Glu246 (cyan box). The expanded views (each rotated to show key movements)
show the critical residues and the linking β-sheet before (green) and after IP3 binding (blue,
PDB code 3UJ4). The carboxy oxygen atoms in Glu246 are shown in magenta. We speculate that
separation of Phe53 and Phe223 when IP3 binds is associated with twisting of the linking β-sheet
and movement of Glu246 towards three other acidic residues (Glu425, Asp426 and Glu428) and that
they may then together form an effective Ca2 + -binding site.
similar to the ‘unzipping’ of interdomain interactions in RyRs
[32,43,52]. The scheme is appealing because IP3 regulates binding
of Ca2 + to IP3Rs and thereby leads to channel gating [34,53]. The
identity of this Ca2 + -binding site is unknown. It is, however, clear
that Ca2 + regulates IP3 binding to the NT only when the SD is
present [42], suggesting that a Ca2 + -binding site within the NT
may be regulated by interactions between the SD and IBC. One
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possibility is that an endogenous EF-hand-like structure might
provide the Ca2 + -binding site and that its interaction with the
1-8-14 motif links IP3 and Ca2 + binding (Figure 7A).
Bioinformatic analyses had suggested the presence of two
possible EF-hand-like structures within the IBC [9,54], but neither
is evident in high-resolution structures of the IBC [55] and NT
[5,56]. Neither have we succeeded in identifying a complementary
partner of the 1-8-14 motif. Another possibility is suggested by
comparison of the structures of the NT with and without IP3 bound
[5,56], which reveal that Phe53 (the first hydrophobic residue
of the 1-8-14 motif) and Phe223 are closely apposed (∼3.9 Å;
1 Å = 0.1 nm), but they move apart (∼5.3 Å) when IP3 binds
(Figure 7B). A β-sheet links Phe223 to Glu246, and the movement
of Phe223 is associated with a repositioning of an acidic residue
in the β-domain of the IBC (Glu246). This brings Glu246 closer
to three other acidic residues (Glu425, Asp426 and Glu428). The
rearrangement is interesting because these four residues have been
proposed to form a Ca2 + -binding site (Ca-I) [55]. Furthermore, a
peptide (residues 378–450) that includes most of these residues
binds Ca2 + , and the binding is abolished by mutation of the acidic
residues [42]. A second possibility is therefore that IP3-evoked
movement of the critical 1-8-14 motif contributes to formation of
an effective Ca2 + -binding site within the IBC by bringing a fourth
acidic residue into appropriate association with three others.
We conclude that a conserved 1-8-14 motif within the SD is
essential for IP3R activation and speculate that its interaction with
either an endogenous CaM-like motif or acidic residues within
the IBC may link IP3 and Ca2 + binding. Inhibition of IP3R by
CaM and related proteins probably results from disruption of this
essential interaction.
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Activation of IP3 receptors requires an endogenous 1-8-14
calmodulin-binding motif
Yi SUN1,2, Ana M. ROSSI1, Taufiq RAHMAN and Colin W. TAYLOR3
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Figure S1 A conserved 1-8-14 motif in all IP3Rs and RyRs
Alignments (with first and last residues numbered) of the N-terminal region of rat IP3R1–IP3R3 (SwissProt accession numbers NP_001007236, NP_112308 and NP_037270 respectively), chicken
IP3R1–IP3R3 (SwissProt accession numbers XP_414438, XP_001235613 and XP_418035 respectively), Xenopus IP3R1–IP3R3 (SwissProt accession numbers NP_001084015, ABP88141 and
ABP88140 respectively), Drosophila IP3R (SwissProt accession number NP_730942), Caenorhabditis elegans IP3R (SwissProt accession number NP_001023170) and rabbit RyR1–RyR3 (SwissProt
accession numbers P11716, P30957 and Q9TS33 respectively) highlighting the residues proposed to form a 1-8-14 CaM-binding motif. The consensus sequence for a 1-8-14 motif is shown in the
first row, with its three critical (1, 8 and 14 hydrophobic residues) and net charge of + 3 to + 6. A similar 1-8-14 motif is conserved in all IP3R, which closely resembles a type A (1-5-8-14) motif,
where position 5 is also a large hydrophobic residue. The motif within IP3Rs differs from a classic 1-8-14 consensus sequence by having a tyrosine residue at position 14. All subtypes of RyR also
have a similar 1-8-14 motif within a similar position in the three-dimensional structure, although the sequence lacks the usual net positive charge of a consensus 1-8-14 motif.
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Figure S2 Mutation of a non-critical residue (K52E) within the 1-8-14 motif
has no effect on IP3 binding or IP3-evoked Ca2 + release
(A) Structure of the SD of IP3R1 (PDB code 1XZZ) highlighting the 1-8-14 motif (red), the
critical 1-8-14 hydrophobic residues (blue) and Lys52 (yellow). (B) Equilibrium competition
binding of IP3 (with 0.75 nM [3H]IP3) to native NT and NTK52E. (C) IP3-evoked Ca2 + release
from DT40-IP3R1 and DT40-IP3R1K52E cells. Results are means +− S.E.M. (n 3).
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An essential 1-8-14 calmodulin-binding motif in IP3 receptors
Table S1 Peptides used in the present study
All peptides were synthesised by Sigma or New England Peptide. The isolelectric point (pI) is shown for each peptide calculated from http://www.innovagen.se/custom-peptide-synthesis/
peptide-property-calculator/peptide-property-calculator.asp. Ac, acetyl.
Peptide Sequence Source pI
MLCK Ac-RRKWQKTGHAVRAIGRL-NH2 Ca2 + –CaM-binding site of smooth muscle MLCK 14.0
1-8-14 Ac-KKFRDALFKLAPMNRY-NH2 Fragment of IP3R1 (residues 51–66) containing the 1-8-14 motif 11.6
1-8-14C Ac-KKERDALFKLAPMNRE-NH2 Inactive form of 1-8-14 peptide (mutations highlighted in bold and underlined) 10.8
1-8-14S Ac-AMRFLKYLPKRFDKNA-NH2 Scrambled form of 1-8-14 peptide 11.6
1-8-14L Ac-LNNPPKKFRDALFKLAPMNRYSAQKQFWKA-NH2 Longer fragment of IP3R1 (residues 46–75) containing the 1-8-14 motif 11.7
Table S2 Primers used in the present study
Primers used for introducing mutations in the N-terminal fragment or full-length IP3R1. The
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